Atsushi Natsume Selected Research

Therapeutics

1/2023	Prediction of Tumor Development and Urine-Based Liquid Biopsy for Molecule-Targeted Therapy of Gliomas.
9/2022	Efficacy of cancer-specific anti-podoplanin CAR-T cells and oncolytic herpes virus G47Δ combination therapy against glioblastoma.
1/2021	Intraoperative seizure outcome of levetiracetam combined with perampanel therapy in patients with glioma undergoing awake brain surgery.
1/2021	Mathematical Modeling and Mutational Analysis Reveal Optimal Therapy to Prevent Malignant Transformation in Grade II IDH-Mutant Gliomas.
10/2019	Spontaneous Tumor Regression of Intracranial Solitary Fibrous Tumor Originating From the Medulla Oblongata: A Case Report and Literature Review.
4/2019	Overview of DNA methylation in adult diffuse gliomas.
1/2018	Cytokine Therapy of Gliomas.
1/2018	Identification of a novel fusion gene HMGA2-EGFR in glioblastoma.
12/2017	Significance of perivascular tumour cells defined by CD109 expression in progression of glioma.
1/2017	Comparing the Efficacy of DeVIC Therapy and High-dose Methotrexate Monotherapy with Whole-brain Radiation Therapy for Newly-diagnosed Primary Central Nervous System Lymphoma: A Single Institution Study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Atsushi Natsume Research Topics

Disease

64	Neoplasms (Cancer) 08/2023 - 09/2005
61	Glioma (Gliomas) 01/2023 - 09/2005
34	Glioblastoma (Glioblastoma Multiforme) 09/2023 - 07/2007
19	Brain Neoplasms (Brain Tumor) 08/2023 - 04/2006
8	Carcinogenesis 08/2023 - 10/2009
7	Meningioma (Meningiomas) 11/2021 - 04/2005
5	Spinal Cord Injuries (Spinal Cord Injury) 02/2021 - 10/2007
3	Lymphoma (Lymphomas) 01/2023 - 11/2011
3	Moyamoya Disease (Moya-Moya Disease) 08/2021 - 01/2020
3	Gliosis 12/2014 - 01/2009
3	Testicular Neoplasms (Testicular Cancer) 06/2010 - 06/2008
2	Microsatellite Instability 08/2022 - 05/2020
2	Thrombosis (Thrombus) 08/2021 - 01/2021
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2021 - 10/2020
2	Germinoma 01/2021 - 01/2021
2	Ependymoma 01/2021 - 03/2009
2	Necrosis 06/2020 - 12/2018
2	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 04/2020 - 05/2019
2	Neoplasm Metastasis (Metastasis) 12/2018 - 05/2006
2	Inflammation (Inflammations) 12/2018 - 05/2018
2	Melanoma (Melanoma, Malignant) 05/2018 - 08/2003
2	Brain Ischemia (Cerebral Ischemia) 11/2017 - 11/2010
2	Leukemia 01/2017 - 03/2013
2	Infections 01/2015 - 07/2014
2	Cognitive Dysfunction 11/2010 - 08/2007
2	Ischemic Stroke 11/2010 - 08/2007
2	Brain Stem Neoplasms (Brain Stem Tumor) 07/2009 - 03/2009
2	Astrocytoma (Pilocytic Astrocytoma) 07/2008 - 08/2007

Drug/Important Bio-Agent (IBA)

20	Temozolomide (Temodar)FDA LinkGeneric 05/2020 - 09/2005
11	Proteins (Proteins, Gene)FDA Link 08/2019 - 01/2004
10	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023 - 03/2013
10	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 08/2007
8	Interferon-betaIBA 05/2020 - 08/2003
7	InterferonsIBA 06/2020 - 07/2006
6	Histones (Histone)IBA 09/2023 - 03/2009
6	Biomarkers (Surrogate Marker)IBA 08/2023 - 06/2010
6	epidermal growth factor receptor VIIIIBA 06/2020 - 12/2010
6	MethyltransferasesIBA 05/2020 - 04/2008
6	Alkylating AgentsIBA 10/2013 - 09/2005
6	AntigensIBA 07/2012 - 06/2008
5	CytokinesIBA 08/2021 - 04/2005
5	ErbB Receptors (EGF Receptor)IBA 06/2020 - 04/2006
5	Chimeric Antigen ReceptorsIBA 06/2020 - 01/2013
5	Peptides (Polypeptides)IBA 01/2019 - 12/2003
5	Liposomes (Liposome)IBA 01/2014 - 08/2003
4	ranimustineIBA 10/2013 - 07/2006
3	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 09/2021 - 03/2012
3	Polycomb Repressive Complex 2IBA 10/2019 - 07/2009
3	GuanineIBA 01/2017 - 04/2012
3	O(6)-Methylguanine-DNA MethyltransferaseIBA 01/2014 - 08/2007
3	Antineoplastic Agents (Antineoplastics)IBA 10/2013 - 09/2005
2	Transcription Factors (Transcription Factor)IBA 09/2023 - 02/2021
2	ChromatinIBA 01/2023 - 07/2013
2	Methotrexate (Mexate)FDA LinkGeneric 01/2023 - 01/2017
2	Glycoproteins (Glycoprotein)IBA 09/2022 - 05/2018
2	ParaffinIBA 08/2022 - 07/2014
2	Formaldehyde (Formol)FDA Link 08/2022 - 07/2014
2	Immune Checkpoint InhibitorsIBA 08/2022 - 12/2016
2	poliferprosan 20 drug combination carmustine (Gliadel)FDA Link 01/2022 - 01/2015
2	RNA (Ribonucleic Acid)IBA 11/2021 - 01/2018
2	GangliosidesIBA 09/2021 - 06/2015
2	A-Form DNA (A-DNA)IBA 09/2021 - 01/2014
2	GD3 ganglioside (GD(3))IBA 08/2021 - 06/2015
2	MicroRNAs (MicroRNA)IBA 04/2021 - 12/2009
2	Tumor Biomarkers (Tumor Markers)IBA 01/2021 - 01/2021
2	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 04/2020 - 05/2019
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2020 - 04/2006
2	AntibodiesIBA 05/2018 - 12/2016
2	Phosphotransferases (Kinase)IBA 01/2018 - 06/2015
2	Oxygen (Dioxygen)IBA 11/2017 - 03/2013
2	Carboplatin (JM8)FDA LinkGeneric 01/2017 - 11/2011
2	Ifosfamide FDA LinkGeneric 01/2017 - 11/2011
2	Etoposide (VP 16)FDA LinkGeneric 01/2017 - 11/2011
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017 - 11/2011
2	Glutamic Acid (Glutamate)FDA Link 12/2014 - 06/2014
2	NimustineIBA 10/2013 - 07/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2013 - 04/2005
2	Small Interfering RNA (siRNA)IBA 06/2013 - 07/2007
2	Green Fluorescent ProteinsIBA 06/2013 - 03/2012
2	Free Radical ScavengersIBA 11/2010 - 08/2007
2	EdaravoneIBA 11/2010 - 08/2007
2	Decitabine FDA Link 03/2009 - 06/2008
1	Cell-Free Nucleic AcidsIBA 08/2023
1	Vincristine (Oncovin)FDA LinkGeneric 01/2023
1	Procarbazine (Matulane)FDA Link 01/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2023
1	alpha-hydroxyglutarateIBA 01/2023
1	Genetic Markers (Genetic Marker)IBA 01/2023
1	Rituximab (Mabthera)FDA Link 01/2023
1	MucinsIBA 09/2022
1	Carmustine (FIVB)FDA Link 01/2022

Therapy/Procedure

29	Therapeutics 01/2023 - 07/2007
22	Radiotherapy 01/2023 - 04/2006
17	Drug Therapy (Chemotherapy) 01/2023 - 04/2006
7	Immunotherapy 01/2020 - 06/2008
3	Precision Medicine 01/2021 - 04/2017
3	Craniotomy 10/2019 - 07/2014
2	Ligation 04/2020 - 05/2019
2	Aftercare (After-Treatment) 07/2015 - 08/2003
2	Spinal Fusion (Spondylosyndesis) 01/2014 - 01/2012